


Healthcare Industry News: HIV/AIDS
News Release - June 14, 2007
Human Genome Sciences Reports That a Phase 2 Study of LymphoStat-B(R) Showed Significant Reductions in Disease Activity in Patients with Active Systemic Lupus Erythematosus
Source: Human Genome Sciences
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
